Allogene Therapeutics (NASDAQ:ALLO) CFO Geoffrey Parker Sells 36,744 Shares
MarketBeat
Allogene Therapeutics, Inc. (NASDAQ:ALLO - Get Free Report) CFO Geoffrey Parker sold 36,744 shares of the business's stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $1.26, for a total value of $46,297.44. Following the transaction, the chief financial officer owned 1,276,796 shares of the company's stock, valued at approximately $1,608,762.96. The trade was a 2.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
NASDAQ:ALLO
